2018 American Transplant Congress
Antihypertensive Medication Use after Kidney Transplant: Practice Variation and Clinical Outcomes
Hypertension is common among kidney transplant (KTx) recipients, but the impact of antihypertensive medication (AHM) choice on patient and graft outcomes is not well defined.We…2018 American Transplant Congress
Implementation of the Lung Allocation Score is Associated with Decreased Mortality in Combined Liver-Lung Allograft Recipients
1School of Medicine, Duke University, Durham, NC; 2Surgery, Duke University, Durham, NC.
Objective: The current system for simultaneous liver-lung transplant (LLT) generally matches a recipient with a donor based on his or her lung allocation score (LAS),…2018 American Transplant Congress
Estimation of Mortality on the Wait List
Baylor University Medical Center, Dallas, TX.
Background: Since the introduction of MELD and MELDNa, the waitlist population has changed. Further, serum creatinine is a poor surrogate of renal dysfunction in patients…2018 American Transplant Congress
Host Factors and Clinical Spectrum of Adenovirus Infection in Pediatric Solid Organ Transplantation: A Closer Look at the Infant, the Toddler and the Child
Pediatrics, Stanford University, Stanford, CA.
Adenovirus (AdV) is increasingly recognized in solid organ transplants (SOT), with reported mortality exceeding 50%. Characterization of AdV infection in the pediatric SOT population is…2018 American Transplant Congress
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015
Background: There are no population-based estimates of the prevalence of end-stage liver disease in the United States, creating challenges in measuring disease burden to inform…2018 American Transplant Congress
Nontuberculous Mycobacteria in Lung Transplant Recipients: Prevalence, Risk Factors and Impact on Survival and Graft Function
University of Alberta, Edmonton, Canada.
BACKGROUND. Nontuberculous mycobacteria (NTM) may colonize or infect lung transplant patients. Due to differences in populations studied and geographical diversity of NTM, risk factors for…2017 American Transplant Congress
Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
Background: The incidence of venous thromboembolism (VTE) in kidney transplant recipients varies widely in the literature. The implications of VTE for morbidity and mortality in…2017 American Transplant Congress
Factors in Association with Sepsis Differ Between Simultaneous Pancreas/Kidney and Single Kidney Transplant Recipients.
As immunosuppressive therapy and allograft survival have improved in simultaneous pancreas/kidney transplant recipients (SPKTRs), the increased incidence of infection has become a major hurdle of…2017 American Transplant Congress
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.
INTRODUCTION. Few objective tests can be easily performed prior to kidney transplantation (KT) to effectively stratify patients by risk of post-KT mortality. The short physical…2017 American Transplant Congress
Protease Inhibitor-Based Regimens Are Associated with Inferior Outcomes in HIV-Infected Kidney Transplant Recipients.
1University of Alabama at Birmingham, Birmingham; 2University of Pennsylvania, Philadelphia
Background: Excellent outcomes have been demonstrated among HIV-infected kidney transplant (KT) recipients when HIV infection is well-controlled. Protease inhibitors (PI) have significant drug-drug interactions with…
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 32
- Next Page »